Showing results (251-260 of 270) with videos related to
Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|September 4, 2024
Retrospective comparative analysis of two medical evacuation systems for Ukrainian patients affected by warAlexandra Mueller, Marta Salek, Aleksandra Oszer, et al.Pediatric Diabetes|April 25, 2017
Monogenic diabetes prevalence among Polish children-Summary of 11 years-long nationwide genetic screening programBeata Małachowska, Maciej Borowiec, Karolina Antosik, et al.Cancer Research Communications|December 5, 2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacyCarmen A Widmer, Ismar Klebic, Natalya Domanitskaya, et al.Pediatric Surgery International|July 10, 2021
Pain resolution and glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet auto-transplantationDamian Grybowski, Piotr J Bachul, Jordan S Pyda, et al.Genes, Chromosomes & Cancer|March 13, 2019
GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemiaJoanna Madzio, Agata Pastorczak, Lukasz Sedek, et al.Archives of Medical Science : AMS|September 21, 2023
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in Poland: analysis of patient series and practical guidelines for breast surgeonsPiotr Pluta, Agnieszka Giza, Małgorzata Kolenda, et al.Leukemia & Lymphoma|October 21, 2016
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemiaMarcin Braun, Agata Pastorczak, Wojciech Fendler, et al.Cancer Research|May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade GliomasSharmistha Pal, David Kozono, Xiaodong Yang, et al.International Immunopharmacology|March 30, 2024
PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity ameliorationMaciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz-Grześ, et al.Cell Transplantation|April 28, 2021
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet AllotransplantationPiotr J Bachul, Karolina Golab, Lindsay Basto, et al.Pageof 27